Literature DB >> 17667481

Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.

Brooke S G Molina, Kate Flory, Stephen P Hinshaw, Andrew R Greiner, L Eugene Arnold, James M Swanson, Lily Hechtman, Peter S Jensen, Benedetto Vitiello, Betsy Hoza, William E Pelham, Glen R Elliott, Karen C Wells, Howard B Abikoff, Robert D Gibbons, Sue Marcus, C Keith Conners, Jeffery N Epstein, Laurence L Greenhill, John S March, Jeffrey H Newcorn, Joanne B Severe, Timothy Wigal.   

Abstract

OBJECTIVE: To compare delinquent behavior and early substance use between the children in the Multimodal Treatment Study of Children With ADHD (MTA; N = 487) and those in a local normative comparison group (n = 272) at 24 and 36 months postrandomization and to test whether these outcomes were predicted by the randomly assigned treatments and subsequent self-selected prescribed medications.
METHOD: Most MTA children were 11 to 13 years old by 36 months. Delinquency seriousness was coded ordinally from multiple measures/reporters; child-reported substance use was binary.
RESULTS: Relative to local normative comparison group, MTA children had significantly higher rates of delinquency (e.g., 27.1% vs. 7.4% at 36 months; p = .000) and substance use (e.g., 17.4% vs. 7.8% at 36 months; p = .001). Children randomized to intensive behavior therapy reported less 24-month substance use than other MTA children (p = .02). Random effects ordinal growth models revealed no other effects of initial treatment assignment on delinquency seriousness or substance use. By 24 and 36 months, more days of prescribed medication were associated with more serious delinquency but not substance use.
CONCLUSIONS: Cause-and-effect relationships between medication treatment and delinquency are unclear; the absence of associations between medication treatment and substance use needs to be re-evaluated at older ages. Findings underscore the need for continuous monitoring of these outcomes as children with attention-deficit/hyperactivity disorder enter adolescence.

Entities:  

Mesh:

Year:  2007        PMID: 17667481     DOI: 10.1097/chi.0b013e3180686d96

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  78 in total

1.  Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.

Authors:  Jamie D Croxtall
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Impact of ADHD and cannabis use on executive functioning in young adults.

Authors:  Leanne Tamm; Jeffery N Epstein; Krista M Lisdahl; Brooke Molina; Susan Tapert; Stephen P Hinshaw; L Eugene Arnold; Katerina Velanova; Howard Abikoff; James M Swanson
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.

Authors:  Andrea L Howard; Brooke S G Molina; James M Swanson; Stephen P Hinshaw; Katherine A Belendiuk; Seth C Harty; L Eugene Arnold; Howard B Abikoff; Lily Hechtman; Annamarie Stehli; Laurence L Greenhill; Jeffrey H Newcorn; Timothy Wigal
Journal:  Addiction       Date:  2015-03-24       Impact factor: 6.526

Review 4.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

5.  Trajectories of Alcohol Initiation and Use During Adolescence: The Role of Stress and Amygdala Reactivity.

Authors:  Nourhan M Elsayed; M Justin Kim; Kristina M Fields; Rene L Olvera; Ahmad R Hariri; Douglas E Williamson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-06-18       Impact factor: 8.829

6.  Association of attention-deficit/hyperactivity disorder and conduct disorder with early tobacco and alcohol use.

Authors:  William B Brinkman; Jeffery N Epstein; Peggy Auinger; Leanne Tamm; Tanya E Froehlich
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

7.  Correlates of early alcohol and drug use in Hispanic adolescents: examining the role of ADHD with comorbid conduct disorder, family, school, and peers.

Authors:  Barbara Lopez; Seth J Schwartz; Guillermo Prado; Shi Huang; Eugenio M Rothe; Wei Wang; Hilda Pantin
Journal:  J Clin Child Adolesc Psychol       Date:  2008-10

8.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

9.  Childhood attention-deficit/hyperactivity disorder (ADHD) and growth in adolescent alcohol use: the roles of functional impairments, ADHD symptom persistence, and parental knowledge.

Authors:  Brooke S G Molina; William E Pelham; JeeWon Cheong; Michael P Marshal; Elizabeth M Gnagy; Patrick J Curran
Journal:  J Abnorm Psychol       Date:  2012-07-30

10.  Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: implications of access, effectiveness, and contextual treatment.

Authors:  Gloria Reeves; Bruno Anthony
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.